G/TBT/N/CAN/573  
 
3 January 2019  
(19-0003) Page: 1/2 
Committee on Technical Barriers to Trade  Original: English/French  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member: CANADA   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible: Department of Health  
Name and address (including telephone and fax numbers, email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
Canada's SPS & TBT Notification Authority and Enquiry Point  
Global Affairs Canada  
Technical Barriers and Regulations Division (TIB)  
111 Sussex Drive, Ottawa, ON K1A 0G2  
Canada  
Telephone: (343) 203 -4273 
Fax: (613) 943 -0346 
E-mail: enquirypoint@international.gc.ca   
3. Notified under Article 2.9.2 [X], 2.10.1 [  ], 5.6.2 [  ], 5.7.1 [  ], other:  
4. Products covered (HS or CCCN  where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  
• 4-Anilino -N-phenethylpiperidine (ANPP) (N -phenyl -1-(2-phenylethyl)piperidine -
4-amine), its salts, derivatives, and analogues and salts of der ivatives and 
analogues  
• Derivatives and analogues of 3,4 -methylenedioxyphenyl -2-propanone, including 
methyl 3 -(1,3-benzodioxol -5-yl)-2-methyloxirane -2-carboxylate (MMDMG)  
• Derivatives and analogues of 1 -phenyl -2-propanone, including methyl 2 -methyl -
3-pheny loxirane -2-carboxylate (BMK methyl glycidate) and 3 -oxo-2-
phenylbutanamide (α -phenylacetoacetamide -APAA)  
• Derivatives and analogues of norfentanyl  
• Benzylfentanyl (N -(1-benzylpiperidin -4-yl)-N-phenylpropionamide), its salts, 
derivatives and analogues  
5. Title, number of pages and language(s) of the notified document: Notice to 
interested parties - Proposed Governor in Council Order amending schedules I and VI to 
the Controlled Drugs and Substances Act and proposed regulations amending the 
schedules to the  Narcotic Control Regulations and the Precursor Control Regulations to 
capture additional substances used in the production of  fentanyls and amphetamines. 
(5 pages available in English and in French)  
6. Description of content: Health Canada has informed t he public, through the publication 
of a notice published in the Canada Gazette, Part I, of its intent to control certain 
chemicals under the Controlled Drugs and Substances Act and its regulations.  G/TBT/N/CAN/573  
 
- 2 - 
 
  7. Objective and rationale, including the nature of urgen t problems where 
applicable: The chemicals in question have been identified in recent years by law 
enforcement as precursors in the illegal production of fentanyls and amphetamines. In 
order to protect the public health and safety, it is necessary to sched ule these chemicals 
under the legislative framework so that law enforcement can take appropriate actions 
against illegal activities involving these substances and that Health Canada can regulate 
legitimate activities with these substances if needed.  
8. Relevant documents:   
• Canada Gazette, Part I, 15 December 2018, Pages 4553 -4557 (available in English 
and French)   
9. Proposed date of adoption:  Health Canada will proceed with the proper regulatory 
approach based on input in response to this notice  
Proposed date of entry into force:  In 2019  
10. Final date for comments: 30 days from notification  
11. Texts available from: National enquiry point [X] or address, telephone and fax 
numbers and email and website addresses, if available, of other body:   
The electronic version of the regulatory text can be downloaded at:  
http://gazette.gc.ca/rp -pr/p1/2018/2018 -12-15/html/notice -avis-eng.html  
http://gazette.gc.ca/rp -pr/p1/2018/2018 -12-15/html/notice -avis-fra.html